InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,712.69
(
-0.28%
)
US TECH 100
19,517.60
(
0.40%
)
Dow Jones
41,794.60
(
-0.61%
)
Brent Oil
75.45
(
0.45%
)
Bitcoin
68,780.42
(
1.42%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

gdollasign

Send PM Follow Ignore
Followers 6
Posts 973
Boards Moderated 0
Alias Born 06/08/2010

gdollasign

Re: lax20m post# 45430

Tuesday, 01/28/2014 10:57:29 AM

Tuesday, January 28, 2014 10:57:29 AM

Post# of 80490
In actuality, in its current indication Iclusig is likely to capture an amount of the market consistent with that in the US.

Is Australia bound by the current U.S. label?

My opinion is that we will see much larger than expected percentages in the second line and a few in the front line both in the U.S. and Australia as we go forward. This off label use will slowly and consistently undermine all available therapies as we learn more on reducing CV events. We do already know that 20% of current Iclusig users are second line per the JPM presentation.

regards,
G$
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up